Evolus (EOLS) Misses Q4 EPS by 13c, Beats on Revenue; Offers FY25 Revenue Guidance

Evolus (NASDAQ: EOLS) reported Q4 EPS of ($0.11), $0.13 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $79 million versus the consensus estimate of $76.96 million.

GUIDANCE:

Evolus sees FY2025 revenue of $345-355 million, versus the consensus of $352 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c